Abstract
The cost of treating cardiovascular disease (CVD) and diabetes is enormous and is set to rise in the coming years. Physical inactivity and sedentary behaviors are major risk factors for these diseases and are estimated to account for several million global deaths annually. Lifestyle interventions, particularly those aimed at enhancing physical activity levels, have a substantial favorable impact on diabetes progression in people at high risk of the disease. Although observational studies and small intervention studies suggest that physical activity might also prevent CVD in people with diabetes, this is not supported by the results of larger randomized controlled trials of lifestyle intervention. The purpose of this review is to provide an overview of the published studies focused on the role of physical activity in CVD prevention in persons with diabetes, and to discuss the implications of these studies’ findings. Our review identified almost 100 studies published in the past decade relevant to this topic.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380:219–29. This paper estimates the impact of physical inactivity on global morbidity and premature mortality.
World Health Organization. The global burden of disease: 2004 update. World Health Organization, Geneva. 2008. http://www.who.int/evidence/bod. Accessed January 17, 2013.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.
Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum; 2011.
• Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34. doi:10.1056/nejm199807233390404. One of the first major studies that impacted policy that showed that people with diabetes are at high risk of coronary heart disease.
Fox CS, Coady S, Sorlie PD, D’Agostino Sr RB, Pencina MJ, Vasan RS, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007;115:1544–50. doi:10.1161/circulationaha.106.658948.
Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev. 1987;3:463–524.
Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14:575–85. doi:10.1016/j.cmet.2011.07.015.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50. doi:10.1056/nejm200105033441801.
Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001;286:1218–27.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403. doi:10.1056/NEJMoa012512.
Batty GD, Shipley MJ, Marmot M, Smith GD. Physical activity and cause-specific mortality in men with type 2 diabetes/impaired glucose tolerance: evidence from the Whitehall study. Diabet Med. 2002;19:580–8.
Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation. 2007;116:2110–8. doi:10.1161/circulationaha.107.729939.
• Helmrich SP, Ragland DR, Leung RW, Paffenbarger Jr RS. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med. 1991;325:147–52. doi:10.1056/nejm199107183250302. A landmark paper underscoring the protective nature of physical activity in type 2 diabetes.
• Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski AS, et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet. 1991;338:774–8. A landmark paper underscoring the protective nature of physical activity in type 2 diabetes.
Hu FB, Sigal RJ, Rich-Edwards JW, Colditz GA, Solomon CG, Willett WC, et al. Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA. 1999;282:1433–9.
Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790–7. doi:10.1056/NEJMoa010492.
Seibaek M, Vestergaard H, Burchardt H, Sloth C, Torp-Pedersen C, Nielsen SL, et al. Insulin resistance and maximal oxygen uptake. Clin Cardiol. 2003;26:515–20.
• Grontved A, Hu FB. Television viewing and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a meta-analysis. JAMA. 2011;305:2448–55. doi:10.1001/jama.2011.812. An important summary paper defining the nature of the relationship between physical activity and sedentary behavior in type 2 diabetes and CVD.
Morais PK, Campbell CS, Sales MM, Motta DF, Moreira SR, Cunha VN, et al. Acute resistance exercise is more effective than aerobic exercise for 24 h blood pressure control in type 2 diabetics. Diabetes Metab. 2011;37:112–7. doi:10.1016/j.diabet.2010.08.008.
•• Ribisl PM, Lang W, Jaramillo SA, Jakicic JM, Stewart KJ, Bahnson J, et al. Exercise capacity and cardiovascular/metabolic characteristics of overweight and obese individuals with type 2 diabetes: the Look AHEAD clinical trial. Diabetes Care. 2007;30:2679–84. doi:10.2337/dc06-2487. The Look AHEAD Study is the most informative randomized clinical trial to date that focuses on the effects of lifestyle intervention on CVD in persons with type 2 diabetes.
•• Sluik D, Buijsse B, Muckelbauer R, Kaaks R, Teucher B, Johnsen NF, et al. Physical activity and mortality in individuals with diabetes mellitus: a prospective study and meta-analysis. Arch Intern Med. 2012:1–11. doi:10.1001/archinternmed.2012.3130. This paper provides new data and meta-analysis of existing data showing that physical activity is favorably associated with mortality in people with type 2 diabetes.
Kadoglou NP, Iliadis F, Angelopoulou N, Sailer N, Fotiadis G, Voliotis K, et al. Cardiorespiratory capacity is associated with favorable cardiovascular risk profile in patients with Type 2 diabetes. J Diabetes Complications. 2009;23:160–6. doi:10.1016/j.jdiacomp.2007.12.008.
Franks PW, Ekelund U, Brage S, Wong MY, Wareham NJ. Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitness? Diabetes Care. 2004;27:1187–93.
Green S, Askew CD, Walker PJ. Effect of type 2 diabetes mellitus on exercise intolerance and the physiological responses to exercise in peripheral arterial disease. Diabetologia. 2007;50:859–66. doi:10.1007/s00125-006-0587-7.
Iijima K, Iimuro S, Shinozaki T, Ohashi Y, Sakurai T, Umegaki H, et al. Lower physical activity is a strong predictor of cardiovascular events in elderly patients with type 2 diabetes mellitus beyond traditional risk factors: the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int. 2012;12 Suppl 1:77–87. doi:10.1111/j.1447-0594.2011.00815.x.
Chacko KM, Bauer TA, Dale RA, Dixon JA, Schrier RW, Estacio RO. Heart rate recovery predicts mortality and cardiovascular events in patients with type 2 diabetes. Med Sci Sports Exerc. 2008;40:288–95. doi:10.1249/mss.0b013e31815c4844.
•• Church TS, Cheng YJ, Earnest CP, Barlow CE, Gibbons LW, Priest EL, et al. Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care. 2004;27:83–8. One of several papers showing that a low aerobic fitness level is an important predictor of mortality in people with type 2 diabetes.
Curtis JM, Horton ES, Bahnson J, Gregg EW, Jakicic JM, Regensteiner JG, et al. Prevalence and predictors of abnormal cardiovascular responses to exercise testing among individuals with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care. 2010;33:901–7. doi:10.2337/dc09-1787.
Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34:1481–6. doi:10.2337/dc10-2415.
Belalcazar LM, Reboussin DM, Haffner SM, Hoogeveen RC, Kriska AM, Schwenke DC, et al. A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care. 2010;33:2297–303. doi:10.2337/dc10-0728.
•• Wing RR. Look Ahead Research Group, Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170:1566–75. doi:10.1001/archinternmed.2010.334. An important outcome paper from Look AHEAD showing that lifestyle intervention does not appear to impact CVD event rates in people with type 2 diabetes.
Kirk A, Mutrie N, MacIntyre P, Fisher M. Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes. Diabetologia. 2004;47:821–32. doi:10.1007/s00125-004-1396-5.
Balducci S, Zanuso S, Cardelli P, Salvi L, Mazzitelli G, Bazuro A, et al. Changes in physical fitness predict improvements in modifiable cardiovascular risk factors independently of body weight loss in subjects with type 2 diabetes participating in the Italian Diabetes and Exercise Study (IDES). Diabetes Care. 2012;35:1347–54. doi:10.2337/dc11-1859.
Johnson ST, Bell GJ, McCargar LJ, Welsh RS, Bell RC. Improved cardiovascular health following a progressive walking and dietary intervention for type 2 diabetes. Diabetes Obes Metab. 2009;11:836–43. doi:10.1111/j.1463-1326.2009.01050.x.
Lima LC, Assis GV, Hiyane W, Almeida WS, Arsa G, Baldissera V, et al. Hypotensive effects of exercise performed around anaerobic threshold in type 2 diabetic patients. Diabetes Res Clin Pract. 2008;81:216–22. doi:10.1016/j.diabres.2008.04.019.
Madden KM, Lockhart C, Cuff D, Potter TF, Meneilly GS. Short-term aerobic exercise reduces arterial stiffness in older adults with type 2 diabetes, hypertension, and hypercholesterolemia. Diabetes Care. 2009;32:1531–5. doi:10.2337/dc09-0149.
Tudor-Locke C, Bell RC, Myers AM, Harris SB, Ecclestone NA, Lauzon N, et al. Controlled outcome evaluation of the First Step Program: a daily physical activity intervention for individuals with type II diabetes. Int J Obes Relat Metab Disord. 2004;28:113–9. doi:10.1038/sj.ijo.0802485.
Eriksson MK, Franks PW, Eliasson M. A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Bjorknas study. PLoS One. 2009;4:e5195. doi:10.1371/journal.pone.0005195.
Lindahl B, Nilsson TK, Borch-Johnsen K, Roder ME, Soderberg S, Widman L, et al. A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance: pronounced short-term impact but long-term adherence problems. Scand J Public Health. 2009;37:434–42. doi:10.1177/1403494808101373.
• Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, et al. Action to control cardiovascular risk in diabetes study group, effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59. doi:10.1056/NEJMoa0802743. An important drug trial showing that targeted glucose-lowering interventions do not diminish CVD event rates in people with type 2 diabetes.
Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, et al. Diabetes Prevention Program Research Group, 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–86. doi:10.1016/s0140-6736(09)61457-4.
Smart-Halajko MC, Kelley-Hedgepeth A, Montefusco MC, Cooper JA, Kopin A, McCaffrey JM, et al. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial. BMC Med Genet. 2011;12:89. doi:10.1186/1471-2350-12-89.
McCaffery JM, Papandonatos GD, Peter I, Huggins GS, Raynor HA, Delahanty LM, et al. Obesity susceptibility loci and dietary intake in the Look AHEAD Trial. Am J Clin Nutr. 2012;95:1477–86. doi:10.3945/ajcn.111.026955.
Peter I, McCaffery JM, Kelley-Hedgepeth A, Hakonarson H, Reis S, Wagenknecht LE, et al. Association of type 2 diabetes susceptibility loci with 1-year weight loss in the look AHEAD clinical trial. Obesity. 2012;20:1675–82. doi:10.1038/oby.2012.11.
Cardoso CR, Maia MD, de Oliveira FP, Leite NC, Salles GF. High fitness is associated with a better cardiovascular risk profile in patients with type 2 diabetes mellitus. Hypertens Res. 2011;34:856–61. doi:10.1038/hr.2011.50.
Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–93. doi:10.1056/NEJMoa021778.
Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J. Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care. 2005;28:799–805.
Jakicic JM, Jaramillo SA, Balasubramanyam A, Bancroft B, Curtis JM, Mathews A, et al. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study. Int J Obes. 2009;33:305–16. doi:10.1038/ijo.2008.280.
Jonker JT, De Laet C, Franco OH, Peeters A, Mackenbach J, Nusselder WJ. Physical activity and life expectancy with and without diabetes: life table analysis of the Framingham Heart Study. Diabetes Care. 2006;29:38–43.
Lau C, Vistisen D, Toft U, Tetens I, Glumer C, Pedersen O, et al. The effects of adding group-based lifestyle counselling to individual counselling on changes in plasma glucose levels in a randomized controlled trial: the Inter99 study. Diabetes Metab. 2011;37:546–52. doi:10.1016/j.diabet.2011.06.001.
Lin CC, Li CI, Liu CS, Lin WY, Fuh MM, Yang SY, et al. Impact of lifestyle-related factors on all-cause and cause-specific mortality in patients with type 2 diabetes: the Taichung Diabetes Study. Diabetes Care. 2012;35:105–12. doi:10.2337/dc11-0930.
Menard J, Payette H, Baillargeon JP, Maheux P, Lepage S, Tessier D, et al. Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial. CMAJ. 2005;173:1457–66. doi:10.1503/cmaj.050054.
Regensteiner JG, Bauer TA, Reusch JE, Quaife RA, Chen MY, Smith SC, et al. Cardiac dysfunction during exercise in uncomplicated type 2 diabetes. Med Sci Sports Exerc. 2009;41:977–84. doi:10.1249/MSS.0b013e3181942051.
Tanasescu M, Leitzmann MF, Rimm EB, Hu FB. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation. 2003;107:2435–9. doi:10.1161/01.cir.0000066906.11109.1f.
Acknowledgments
The authors’ opinions are the result of many past interactions with mentors, colleagues, collaborators, students, and fellows, for which the authors express their thanks. P. W. Franks is funded by EXODIAB, Lund University, Umeå University, Region Skåne health authority, the Swedish Diabetes Association, the Swedish Heart Lung Foundation, the Swedish Research Council, the European Union, Novo Nordisk, and the National Institutes of Health. R. W. Koivula was funded by a grant from the Innovative Medicines Initiative Joint Undertaking under grant agreement n 115317 (DIRECT) as part of the European Union’s Seventh Framework Program (FP7/2007-2013) (to PWF) and a STAR Novo Nordisk co-financed PhD fellowship. This work was done as part of the DIRECT consortium. Å. B. Tornberg received funding from the World Village of Women’s Sports Foundation.
Conflict of Interest
Robert W. Koivula declares that he has no conflict of interest.
Åsa B. Tornberg declares that he has no conflict of interest.
Paul W. Franks declares that he has no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koivula, R.W., Tornberg, Å.B. & Franks, P.W. Exercise and Diabetes-Related Cardiovascular Disease: Systematic Review of Published Evidence from Observational Studies and Clinical Trials. Curr Diab Rep 13, 372–380 (2013). https://doi.org/10.1007/s11892-013-0373-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11892-013-0373-0